Coronary Pressure Market Report 2026

Coronary Pressure Market Overview

• Coronary Pressure market size has reached to $19.08 billion in 2025 • Expected to grow to $30.38 billion in 2030 at a compound annual growth rate (CAGR) of 9.7% • Growth Driver: Increasing Cardiovascular Disease Fuels Growth In Coronary Pressure Market • Market Trend: Advancements In Coronary Intravascular Lithotripsy Technology • North America was the largest region in 2025.

What Is Covered Under Coronary Pressure Market?

Coronary pressure refers to the pressure within the coronary arteries, which deliver blood and oxygen to the heart muscle. It is a vital metric for evaluating the sufficiency of blood flow and oxygen supply to the heart. Influenced by factors such as heart rate, blood volume, and arterial resistance, monitoring coronary pressure is essential in diagnosing and managing coronary artery disease. The main device types of coronary pressure are sphygmomanometers, automated blood pressure monitors, blood pressure (BP) transducers, and ambulatory blood pressure monitors. A sphygmomanometer is a device used to measure blood pressure manually and typically consists of an inflatable cuff, a pressure gauge, and a bulb for inflating the cuff. The technology includes digital, aneroid, and wearable, and it is used by various end users such as hospitals, cardiac care centers, ambulatory centers, homecare, and academic institutes.

What Is The Coronary Pressure Market Growth Forecast?

The coronary pressure market size is expected to see strong growth in the next few years. It will grow to $30.38 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to advancements in wearable technology, growing homecare adoption, increased cardiac screening programs, rising preventive cardiology focus, digital health integration. Major trends in the forecast period include rising use of invasive pressure monitoring, growing adoption of wearable monitoring devices, expansion of ambulatory blood pressure monitoring, integration with cardiac diagnostic systems, increased focus on early risk assessment.

What Is The Driver Of The Coronary Pressure Market?

The increasing prevalence of cardiovascular diseases is expected to propel the growth of the coronary pressure market going forward. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, hypertension, and heart failure, often linked to lifestyle factors and genetics. Cardiovascular disease rates are on the rise owing to several factors, such as unhealthy diets, sedentary lifestyles, and increasing obesity. Coronary pressure devices help in assessing and managing cardiovascular diseases by measuring coronary artery pressures, guiding treatment decisions, and improving outcomes for patients with heart conditions. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2023, cardiovascular disease claimed 919,032 lives, accounting for one in every three deaths. Coronary heart disease remained the most prevalent form of heart disease, and notably, about one in six deaths from cardiovascular diseases occurred among adults younger than 65 years. Therefore, the increasing prevalence of cardiovascular diseases is driving the coronary pressure industry.

Key Players In The Global Coronary Pressure Market

Major companies operating in the coronary pressure market are Cardinal Health Inc., General Electric Company, Abbott Laboratories, Medtronic plc, Siemens Healthineers, Koninklijke Philips, Baxter International Inc., Boston Scientific Corporation, Terumo Corporation, Omron Corporation, Edwards Lifesciences, Zoll Medical Corporation, Nihon Kohden Corporation, LivaNova plc, AtriCure, Rossmax, A&D Medical, St. Jude Medical, HeartWare International

Global Coronary Pressure Market Trends and Insights

Major companies operating in the coronary pressure market are focusing on developing innovative products such as coronary intravascular lithotripsy (IVL) catheters to enhance the accuracy of coronary assessments and improve outcomes in treating calcified lesions. Coronary intravascular lithotripsy (IVL) catheters are balloon-based devices that emit acoustic pressure waves to fracture hardened calcium inside coronary arteries, helping improve vessel compliance and enabling safer, more effective stent expansion during coronary interventions. For instance, in May 2023, Shockwave Medical Inc., a US-based cardiovascular device company, launched the Shockwave C2+ Coronary IVL Catheter, an advanced catheter for the treatment of severely calcified coronary lesions. The C2+ catheter is composed of a balloon catheter with integrated lithotripsy emitters and is compatible with 0.014″ guidewires and 5 Fr guiding catheters; it functions by inflating at low pressure (~4 atm) and then emitting sonic pulses (50 % more pulses than the previous C2 model) to fracture calcified plaque before stenting; its unique features include improved deliverability and ability to treat longer lesions and more challenging eccentric or nodular calcium, applications including pre‐stent lesion preparation in complex calcified de novo coronary artery disease, and benefits such as more predictable stent expansion, reduced need for high‐pressure post-dilatation, and lower risk of complication from vessel damage.

What Are Latest Mergers And Acquisitions In The Coronary Pressure Market?

In May 2024, Johnson & Johnson Services Inc., a US-based pharmaceutical and medical technology company, acquired Shockwave Medical Inc. for an undisclosed amount. Through this acquisition, Johnson & Johnson aims to strategically enhance its presence and bolster its position in the cardiovascular market, enhance treatment options for patients, and drive long-term financial growth. Shockwave Medical Inc. is a US-based provider of coronary pressure devices.

What Defines the Coronary Pressure Market?

The coronary pressure market consists of sales of fractional flow reserve (FFR) wire, instantaneous wave-free ratio (iFR) wire, pressure monitoring manifolds, and pressure measurement devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Coronary Pressure Market Report 2026?

The coronary pressure market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the coronary pressure industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.